Cargando…

Multimorbidity adjusted years lost to disability rates calculated through Monte-Carlo simulation in Korea

OBJECTIVES: To efficiently utilize limited health and medical resources, it is necessary to accurately measure the level of health, which requires estimating the multimorbidity-corrected burden of disease. METHODS: This study used 2015 and 2016 data from the National Health Insurance Service, and em...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Yoonhee, Choi, Eun Jeong, Park, Bomi, Lee, Hye Ah, Lee, Eun-Kyung, Park, Hyesook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Epidemiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089703/
https://www.ncbi.nlm.nih.gov/pubmed/36265517
http://dx.doi.org/10.4178/epih.e2022090
Descripción
Sumario:OBJECTIVES: To efficiently utilize limited health and medical resources, it is necessary to accurately measure the level of health, which requires estimating the multimorbidity-corrected burden of disease. METHODS: This study used 2015 and 2016 data from the National Health Insurance Service, and employed the list of diseases defined in a Korean study of the burden of disease, the criteria for prevalence, and the “cause–sequelae–health state” disease system. When calculating the years lost to disability (YLD), multimorbidity was corrected using Monte-Carlo simulation. RESULTS: Correcting for multimorbidity changed YLD at all ages in Korea by −1.2% (95% confidence interval [CI], −24.1 to 3.6) in males and −12.4% (95% CI, −23.0 to 0.3) in females in 2015, and by −10.8% (95% CI, −24.1 to 4.6) in males and −11.1% (95% CI, −22.8 to 1.7) in females in 2016. The YLD rate for non-communicable diseases in males decreased more than that of other disease groups in both years, by −11.8% (95% CI, −19.5 to 3.6) and −11.5% (95% CI, −19.3 to −3.0), respectively. The overall YLD rate changed by −1.3% in the 5-year to 9-year age group, and the magnitude of this change remained similar until the 10–19-year age group, gradually decreased after 20 years of age, and steeply increased to more than 10% in those aged 60 and older. CONCLUSIONS: Calculations of YLD should adjust for multimorbidity, as the disease burden can otherwise be overestimated for the elderly, who tend to exhibit a high prevalence of multimorbidity.